Abstract: Photoactive compounds are disclosed. The disclosed photoactive compounds include metal complexes with dipyrromethene-based ligands, which can be substituted with a variety of different side chains or groups or can include various fused ring configurations, such as including aromatic or heteroaromatic groups. The metal complexes may include two dipyrromethene-based ligands, which can be the same or different. The photoactive compounds can be used as photoactive materials in organic photovoltaic devices, such as visibly transparent or opaque photovoltaic devices.

Abstract: The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.

Abstract: A medical implant or a method of packaging a medical implant is provided. In one embodiment, the medical implant may be packaged to facilitate remaining hydrophilic for an extended duration of time after packaging.

Abstract: Aspects of the disclosure relate to using synthetic DNA stranding and mutant nucleotide processes to conduct enterprise market volatility predictions. In some embodiments, a computing platform may receive raw market data from a plurality of lines of business of an enterprise organization. Thereafter, the computing platform may preprocess the raw market data to obtain enterprise level market data, execute synthetic DNA stranding of the enterprise level market data to obtain synthetic DNA stranded market data, run the synthetic DNA stranded market data through one or more market volatility models, and compile results from the market volatility models on the synthetic DNA stranded market data. The computing platform may transmit results from the market volatility models on the synthetic DNA stranded market data. The transmitted results may be configured to display a market application interface that includes market volatility forecasting parameters based on results of the market volatility models.

Abstract: Aspects of the disclosure relate to using synthetic DNA stranding and mutant nucleotide processes to conduct enterprise market volatility predictions. In some embodiments, a computing platform may receive market data from a plurality of lines of business across an enterprise, wherein the market data is received in a raw, uncompressed format. Thereafter, the computing platform may assimilate and preprocess the market data to output vectored market data. The computing platform may perform a synthetic DNA stranding process on the vectored market data to create one or more strands of synthetic DNA market data, and output the one or more strands of synthetic DNA market data to a synthetic DNA client server, wherein the one or more stands of synthetic DNA market data is configured for input in a market volatility prediction model.

Abstract: Aspects of the disclosure relate to using synthetic DNA stranding and mutant nucleotide processes to conduct enterprise market volatility predictions. In some embodiments, a computing platform may initiate a set of instructions associated with performing an action on a synthetic DNA market data set associated with a plurality of lines of business across an enterprise organization. Thereafter, the computing platform may convert the set of instructions to a mutant nucleotide sequence, and insert the mutant nucleotide sequence into the synthetic DNA market data set. The computing platform may extract, using the mutant nucleotide sequence, target information from the synthetic DNA market data set, and validate the target information to detect one or more anomalies. The computing platform may remove the one or more data anomalies, and subsequently output a validated synthetic DNA market data set to a synthetic DNA client server.

Abstract: A voice and dialect matching computing device processes audio signals received from two sources to authenticate and secure information associated with creation of an electronic transaction. This voice based computing device automatically processes audio signals to identify participants based on voice information and/or dialect information. The voice based computing device compares a vocal signal and/or dialect information using an intelligent processing unit (e.g., an artificial intelligence/machine learning based model) and/or using historical information stored in a central dynamic data store. The processed audio signals are decomposed into at least two signals, where a first signal may be used as a trigger to activate processing of an electronic transaction by a smart contract hub computing device. The second signal includes attributes of the electronic transaction which may then be encrypted.

Abstract: Compounds, compositions and methods are provided for the inhibition of GBP1. The subject inhibitor compounds can act by inhibiting GBP1 alone and/or GBP1: pro-survival kinase (e.g. serine/threonine-protein kinase pim-1 (PIM1)) interactions. Aspects of the subject methods include contacting a cellular sample with a GBP 1 inhibitor to inhibit the GBP 1 alone and/or GBP 1: PIM 1 interactions. Also provided are compositions and methods for treating cancer. In certain cases the cancer is resistant towards chemotherapy and radiation therapy.

Abstract: ?-NETA analogs are provided for the treatment of inflammatory disease.

Abstract: The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.

Abstract: The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.

Abstract: The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.

Abstract: The present invention generally relates to a system and method for treating spent caustic effluent using chlorine dioxide solution. The system comprises a spent caustic storage tank for receiving spent caustic obtained from refinery operations; an acid storage container connected to the spent caustic storage tank for neutralizing free alkali content with a mineral acid to eliminate unwanted chemical reactions associated with free caustic present in spent caustic with ClO2; a heat exchanger unit engaged for reducing temperature of spent caustic to 35-45° C. from high temperature raised due to heat of neutralisation at least one of a cavitation (mixing) chamber or venturi mixing equipment mechanically connected downstream of the heat exchanger unit for adding CIO solution to the spent caustic solution to oxidize sulphide/thiols content for complete reduction of sulphide/mercaptane and reduction of 80-90% of COD.

Abstract: A system and method for providing emergency access control for a unified data platform allowing a user to request access to a segregated data set of the unified data platform where the user can automatically be granted the minimum required access permission, therefore providing the user limited access only to the necessary data required for maintenance purposes, and where the access permission is based off authorization information associated with the user for various segregated data sets and associated parameters.

Abstract: A virtual automated market maker system and method for creating prediction markets is disclosed. The method comprises receiving a request for creating a prediction market for a binary event from event creator. The method comprises receiving initial odds for the binary event from the event creator. Furthermore, the method comprises generating YES virtual coins and NO virtual coins based on total number of the desired virtual coins and the received initial odds. Also, the method comprises computing YES price value and NO price value based on the generated YES virtual coins, the NO virtual coins and the sum of the YES virtual coins and the NO virtual coins. Moreover, the method comprises determining whether there exists a transaction for the received binary event. Also, the method comprises adjusting the computed YES price value for the YES outcome and the NO price value of the NO outcome based on the transaction.

Abstract: A bone preparation system for enhancing cementless osseointegration of bone implants includes a gas delivery device, for cleaning the bone surface of the bone to receive the implant, and a supply of orthobiologic material or orthobiologic materials for applying to the cleaned bone surface and/or to the implant surface, which promotes bone cell generation at the interface between the bone surface and the implant surface to enhance the osseointegration of the implant to the bone.

Abstract: The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.

Abstract: Aspects of the disclosure relate to using synthetic DNA stranding and mutant nucleotide processes to conduct enterprise market volatility predictions. In some embodiments, a computing platform may initiate a set of instructions associated with performing an action on a synthetic DNA market data set associated with a plurality of lines of business across an enterprise organization. Thereafter, the computing platform may convert the set of instructions to a mutant nucleotide sequence, and insert the mutant nucleotide sequence into the synthetic DNA market data set. The computing platform may extract, using the mutant nucleotide sequence, target information from the synthetic DNA market data set, and validate the target information to detect one or more anomalies. The computing platform may remove the one or more data anomalies, and subsequently output a validated synthetic DNA market data set to a synthetic DNA client server.

Abstract: Aspects of the disclosure relate to using synthetic DNA stranding and mutant nucleotide processes to conduct enterprise market volatility predictions. In some embodiments, a computing platform may receive raw market data from a plurality of lines of business of an enterprise organization. Thereafter, the computing platform may preprocess the raw market data to obtain enterprise level market data, execute synthetic DNA stranding of the enterprise level market data to obtain synthetic DNA stranded market data, run the synthetic DNA stranded market data through one or more market volatility models, and compile results from the market volatility models on the synthetic DNA stranded market data. The computing platform may transmit results from the market volatility models on the synthetic DNA stranded market data. The transmitted results may be configured to display a market application interface that includes market volatility forecasting parameters based on results of the market volatility models.

Abstract: Aspects of the disclosure relate to using synthetic DNA stranding and mutant nucleotide processes to conduct enterprise market volatility predictions. In some embodiments, a computing platform may receive market data from a plurality of lines of business across an enterprise, wherein the market data is received in a raw, uncompressed format. Thereafter, the computing platform may assimilate and preprocess the market data to output vectored market data. The computing platform may perform a synthetic DNA stranding process on the vectored market data to create one or more strands of synthetic DNA market data, and output the one or more strands of synthetic DNA market data to a synthetic DNA client server, wherein the one or more stands of synthetic DNA market data is configured for input in a market volatility prediction model.